Literature DB >> 31803307

Clinical Presentation, Diagnosis, and Management of Air Embolism During Endoscopic Retrograde Cholangiopancreatography.

Muhammad Haisum Maqsood1, Nayab Mirza1, Muhammad Asad Hanif1, Hira Hanif2, Maleeha Saleem3, Muhammad Arqam Maqsood4, Ilsa Fatima5, Muhammad Moiz Tahir1.   

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) is a minimally invasive procedure that is widely used by endoscopists and has a robust therapeutic profile. It uses endoscopy and imaging for a variety of diagnostic as well as therapeutic purposes. It is used for the management of a lot of pancreaticobiliary diseases such as obstructive jaundice, obstruction related to bile ducts, pancreatic biliary tumors, and traumatic or iatrogenic damage to the bile ducts. Other therapeutic interventions that can be done via ERCP include sphincterotomy, dilation of strictures, removal of biliary stones and placement of stents. Air embolism presents with cardiovascular, pulmonary, and neurologic signs and symptoms. Treatment of air embolism should be started early in suspected cases, and it should be in the differential diagnoses of various complications secondary to high risk of ERCP, especially if a cardiopulmonary compromise is present. Air embolism is rare but a serious complication associated with ERCP. The physicians must keep this in mind while performing ERCP in patients with predisposing risk factors. This review highlights the mechanism, causes, risk factors, pathophysiology, clinical signs, diagnostic modalities, treatment, and preventive measures to deal with this catastrophic complication. Copyright 2019, Maqsood et al.

Entities:  

Keywords:  Air embolism; Complications; Endoscopic retrograde cholangiopancreatography; Endoscopy; Pancreaticobiliary diseases; Precordial Doppler ultrasound; Therapeutic procedure

Year:  2019        PMID: 31803307      PMCID: PMC6879026          DOI: 10.14740/gr1208

Source DB:  PubMed          Journal:  Gastroenterology Res        ISSN: 1918-2805


Introduction

Endoscopic retrograde cholangiopancreatography (ERCP) is a minimally invasive procedure which uses endoscopy and imaging for diagnostic and therapeutic purposes [1]. Its advantages in the management of pancreaticobiliary diseases are superseded by a higher potential for severe complications than any other standard endoscopic technique due to an extreme degree of expertise, procedural complexity and risk of complications [2]. Since its development in 1968, it has been in use as an excellent diagnostic tool for pancreaticobiliary diseases [3]. However, lately, its diagnostic use has transformed into an almost exclusively therapeutic procedure in support of less invasive techniques such as abdominal ultrasound (AUS) and magnetic resonance cholangiopancreatography (MRCP) [4]. Air embolism after ERCP is an uncommon complication that can be fatal if not recognized and treated early [5]. Air embolism is due to insufflation of high-pressured air to improve visualization. Different methods contributing to air embolism may include intramural dissection due to mucosal damage from high pressures, biliary venous fistulas, and blunt abdominal trauma [6]. According to Afreen et al there is a high incidence of 2.4% for venous air embolism (VAE) during ERCP which calls for the practitioners to be aware of it. Efficient detection can lead to early management, resulting in fewer consequences [7]. Air embolism due to ERCP is because of an abnormal entrance of air that is insufflated during the procedure into the arterial or venous vasculature due to disruption of a mucosal vascular barrier. Its severity is related to both the amount and the velocity with which the air is introduced [8, 9]. The amount of air that causes a circulatory air embolism ranges from 10 to 480 mL, depending on the speed of air entering into circulation and the organ vasculature into which the embolus extends [10]. Air embolism is a serious complication that can occur during an endoscopic procedure, and it can cause significant morbidity and mortality if not diagnosed early [11]. Therefore, it is imperative to keep the possibility of air embolism in mind whenever a patient experiences sudden deterioration of vitals or neurologic compromise, apart from other significant causes. We write this review article to describe the mechanism, causes, risk factors, pathophysiology, clinical signs, diagnostic modalities, treatment and preventive measures to deal with this catastrophic complication.

Uses and Complications of ERCP

ERCP is an advanced endoscopic technique with a variety of diagnostic as well as therapeutic uses. It is used for the management of a lot of pancreaticobiliary diseases such as obstructive jaundice, obstruction related to bile ducts and pancreaticobiliary tumors, and traumatic or iatrogenic damage to the bile ducts [12]. Other therapeutic interventions that can be done via ERCP include sphincterotomy, dilation of strictures, removal of biliary stones, and placement of stents. Over 500,000 ERCPs are performed annually in the USA [13]. The Center for Medicare and Medicaid Services states that from 2000 to 2010, the number of cases of ERCP performed has risen from 233,378 to 288,715, a 23.7% increase [14, 15]. Gastrointestinal (GI) endoscopy involves insufflation of air at up to 2 L/min [16]. Cholangitis, hemorrhage, pancreatitis and perforation are the most common complications from ERCP [17]. Less common complications of ERCP include cardiac arrest, air in hepatic veins, pulmonary and cerebral air embolism, and paradoxical air embolism [17, 18]. Cardiopulmonary complications of ERCP include arrhythmias, hypoxemia and myocardial ischemia, which is usually transitory [17, 19]. Christensen and colleagues reported that 30% (12/40) patients underwent ST-segment changes suggesting myocardial ischemia. However, none of them had coronary symptoms on exercise stress test [19].

Pathophysiology of ERCP-Induced Air Embolism

Patients who underwent prior endoscopic procedures are at a significantly higher risk for air embolism during ERCP. Placement of metal stents into the biliary tract may be associated with an increased risk of vascular injury, which favors air embolism [20]. The possible explanations of VAE during ERCP include mechanical alteration of the bile duct wall by the endoscope, development of bilio-venous shunts and spontaneous transgression of air from bile ducts [21]. Intramural dissection of air into the portal venous system via injured duodenal vein radicles can also occur following ERCP and sphincterotomy [6]. Other risk factors for air embolism during ERCP are inflammatory processes of the digestive system (pylephlebitis, inflammation of bile duct, inflammatory bowel disease, abscess and mesenteric ischemia), percutaneous biliary drainage, liver abscess, gastrointestinal tumors, transjugular intrahepatic portosystemic shunt (TIPS) and penetrating liver trauma [22]. Portal vein cannulation is also a cause of air embolism during ERCP [23, 24]. Air embolism rate associated with ERCP may be as high as 10% [25]. During ERCP, air from the luminal wall can enter into the venous or arterial system or both depending on where the primary insult began. When the gas enters a venous structure, VAE occurs, and the involvement of the organs depends upon the extension of the embolism. It can travel from the superior vena cava (SVC) through the right heart and end up causing pulmonary air embolism or can also pass through the SVC upwards into the cerebral veins leading to paradoxical air embolism. Also when a venous embolism is large enough, it can pass through the pulmonary veins and the left heart to the arterial circulation and end up lodging into cerebral arteries, one of the mechanisms behind paradoxical air embolism [26-28]. A patent foramen ovale can lead to paradoxical embolism [29]. Other than a patent foramen ovale, air embolus can also pass into the systemic circulation via a transpulmonary shunt [6, 30, 31]. Air-blood interface created due to the air embolus causes platelet activation, which leads to a further decline in blood flow across the pulmonary circulation [30].

Clinical Signs and Symptoms

As most patients are sedated during the procedure, the clinical index of suspicion of air embolism should be kept in mind. Patients often experience severe and rapid clinical deterioration, so many cases often remain undiagnosed and are identified during post mortem [32]. Cardiovascular symptoms and signs include chest pain, dizziness, tachycardia or bradycardia, crackles, acute onset right-sided heart failure, hypotension, elevated jugular venous pressure, mill wheel murmur (loud churning sound likely from mixing of air and blood in the right ventricle that is heard throughout the cardiac cycle), cardiac arrest, arrhythmias like supraventricular tachycardia (SVT), ventricular tachycardia (VT), asystole or pulseless electrical activity [25, 31, 33-35]. Seizures, headache, focal neurological deficits, paraplegia or quadriparesis, altered mental status or failure to regain consciousness after the procedure, hemiparesis, pupillary dilation, skin mottling, and coma are some of the neurological signs and symptoms that may be present if cerebral involvement occurs [36-39]. Pulmonary symptoms and signs include respiratory failure, tachypnea, cyanosis, rales and wheezing [40]. A sudden decrease in end-tidal CO2 (EtCO2) in intubated patients may be a useful early sign of air embolism during ERCP. Nine out of the 10 reported fatalities from air embolism during ERCP occurred due to systemic embolization, which highlights the importance of early detection [41]. Severe cases of VAE may result in cardiovascular collapse. It was thought to be due to an “air-lock” phenomenon which resulted in large amounts of air entering into the right heart which prevented blood from exiting the ventricle. It now appears more likely that the acute increase in right ventricular pressure and decreased perfusion pressure leads to right ventricular ischemia, right heart failure, arrhythmias, and ultimately, cardiovascular collapse [7].

Diagnosis

Precordial Doppler ultrasound (PDU) is a useful method to detect VAE during ERCP and should especially be considered in high-risk procedures [42]. It is an effective, inexpensive, and noninvasive monitoring device in which heart tone changes, usually called “mill-wheel murmur,” are a hallmark of VAE [8]. VAE may be diagnosed with transesophageal or transthoracic echocardiography [28]. Air can be seen in significant amount in the right heart. Pulmonary artery hypertension and right ventricular strain on electrocardiogram can also be seen. Because of a decrease in cardiac output, capnography demonstrates a decrease in EtCO2. If air is being used for insufflation, nitrogen will be seen among the expired gases [43]. Central venous pressure can be increased by volume expansion, which can prevent further embolization. A computed tomography scan can be done if systemic air embolism is suspected to identify air in the affected organs only after initial stabilization and resuscitation of the patient [44]. Moreover, pulmonary embolism should always be in the differentials of hemodynamic instability [11].

Management

Treatment of air embolism should be started early in suspected cases, and it should be in the differential diagnoses of various complications secondary to high-risk ERCP, especially if a cardiopulmonary compromise is present [8]. Management of VAE is conservative with intravenous (IV) antibiotics and decompression via nasogastric tube [10]. If air embolism becomes evident during the procedure, the procedure should be discontinued, and hemodynamic and respiratory stabilization should be performed [45]. It is also recommended to perform an immediate echocardiogram [28]. If echocardiography confirms air in the right heart, the central catheter is inserted. High-flow 100% oxygen, Trendelenburg, and left lateral decubitus positions are used to prevent air migrating to the brain and to force the air into the outflow tract of the right ventricle [11]. Hyperbaric oxygen therapy is considered first-line treatment as it reduces the size of the air bubbles, increases nitrogen absorption, and increases blood oxygen concentration, which helps reduce cerebral ischemic injury [25]. Hyperbaric oxygen therapy in a chamber with a pressure of 2.5 atm for more than 2 h has shown to improve survival in patients with air embolisms from multiple sources [46]. Athauda et al reported a case where therapeutic hypothermia was used in cerebral air embolism caused by ERCP when hyperbaric oxygen therapy was not available. It is one of the secondary options, but more studies need to be done on this [38]. There is no routine recommendation of anticoagulation as there is a risk of hemorrhagic transformation of ischemic tissue. The only indication of anticoagulation in air embolism is the concomitant development of pulmonary embolism [11].

Mortality and Morbidity of Air Embolism

Shaikh et al mentioned in their review that vascular air embolism has a mortality rate of 48-80% [47]. The lethal dose has been estimated to be 3 - 5 mL/kg and 300 - 500 mL of gas injected at a rate of 100 mL/s has been found to be fatal for humans [48]. Muley et al concluded that 17.2% (41/238) patients undergoing neurosurgery had a fall in EtCO2. Its monitoring is an important parameter to consider early in the course of suspected VAE. Survivors of VAE can have long-term neurological effects [49].

Prophylactic Measures to Decrease the Risk of Air Embolism

Kwan and colleagues used CO2 instead of air, which reduced the risk of embolism as CO2 is absorbed more easily. It is also associated with less pain after the procedure and less abdominal distension [50]. The presence of congenital right-to-left shunt should be ruled out in all patients considered for ERCP, possibly via echocardiography before the procedure [5]. Personnel expertise is required to rapidly insert a pulmonary artery catheter into the right heart in order to drain air and should be immediately available [51]. Cotton et al highlighted that for diagnostic purposes, MRCP can now be used and ERCP should be reserved for the procedures that need therapeutic intervention [52].

Conclusions

Air embolism is a rare but serious complication associated with ERCP that must be considered, especially in high-risk cases. The endoscopist must keep this in mind while performing ERCP in patients with predisposing risk factors. Bedside Doppler may be used early to detect air in the right heart. Treatment with high-flow oxygen and resuscitation should be performed early in high-risk cases to prevent the fatal outcomes. After initial stabilization, diagnosis is then confirmed. Aspiration with the help of an expert should be readily available in high-risk cases. All high-risk cases should be intubated with the help of an anesthetist to detect reducing EtCO2 levels to initiate early treatment and reduce the morbidity and mortality associated with this.
  51 in total

1.  Cardiac air embolism after endoscopic retrograde cholangiopancreatography in a patient with blunt hepatic trauma.

Authors:  Ismaël Mohammedi; Charles Ber; Olivier Peguet; Thierry Ould-Aoudia; Serge Duperret; Paul Petit
Journal:  J Trauma       Date:  2002-12

2.  Fatal cerebral air embolism after endoscopic retrograde cholangiopancreatography.

Authors:  L Stabile; M Cigada; D Stillittano; E Morandi; M Zaffroni; G Rossi; G Lapichino
Journal:  Acta Anaesthesiol Scand       Date:  2006-05       Impact factor: 2.105

3.  A rare complication during ERCP and sphincterotomy: placement of an endoscopic nasobiliary drainage tube in the portal vein.

Authors:  Mitoshi Furuzono; Nobuto Hirata; Junko Saitou; Sou Nakaji
Journal:  Gastrointest Endosc       Date:  2009-06-24       Impact factor: 9.427

4.  Fatal venous air embolism: proof and volumetry by helical CT.

Authors:  H U Kauczor; T Riepert; B Wolcke; G Lasczkowski; P Mildenberger
Journal:  Eur J Radiol       Date:  1995-12-15       Impact factor: 3.528

5.  Development of a system for the automatic detection of air embolism using a precordial Doppler.

Authors:  Ana Tedim; Pedro Amorim; Ana Castro
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2014

6.  Two Cardiac Arrests Because of Venous Air Embolism During Endoscopic Retrograde Cholangiopancreatography: A Case Report.

Authors:  Joseph M Sisk; Monica D Choi; Andrew B Casabianca; Ali M Hassan
Journal:  A A Case Rep       Date:  2017-02-01

7.  Cerebral air embolism resulting from invasive medical procedures. Treatment with hyperbaric oxygen.

Authors:  B P Murphy; F J Harford; F S Cramer
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

8.  ECG changes during endoscopic retrograde cholangio-pancreatography and coronary artery disease.

Authors:  Merete Christensen; Thor Milland; Verner Rasmussen; Svend Schulze; Jacob Rosenberg
Journal:  Scand J Gastroenterol       Date:  2005-06       Impact factor: 2.423

9.  Biliary metal stents and air embolism: a note of caution.

Authors:  C Rabe; Z Balta; U Wüllner; J Heller; C Hammerstingl; K Tiemann; T Sommer; M Schepke; H-P Fischer; T Sauerbruch
Journal:  Endoscopy       Date:  2006-02-08       Impact factor: 10.093

10.  Incidence of Venous Air Embolism During Endoscopic Retrograde Cholangiopancreatography.

Authors:  Lubana K Afreen; Ayesha S Bryant; Tetsuzo Nakayama; Timothy J Ness; Keith A Jones; Charity J Morgan; Charles M Wilcox; Mark C Phillips
Journal:  Anesth Analg       Date:  2018-08       Impact factor: 5.108

View more
  3 in total

1.  When in Trouble Think of the Bubble: Paradoxical Cerebral Arterial Gas Embolism after Endoscopic Retrograde Cholangiopancreatography.

Authors:  Konstantinos Ekmektzoglou; Georgios Alexandrakis; Konstantinos Dimopoulos; Panagiotis Tsibouris; Chrysostomos Kalantzis; Erasmia Vlachou; Periklis Apostolopoulos
Journal:  Case Rep Gastroenterol       Date:  2021-04-29

2.  Suspected cerebrovascular air embolism during endoscopic esophageal varices ligation under sedation with fatal outcome: A case report.

Authors:  Cuo-Mao-Ji Zhang; Xiao Wang
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

3.  Massive cerebral air embolism following percutaneous transhepatic biliary drainage: A case report.

Authors:  Jae Ho Lee; Ha Young Lee; Myung Kwan Lim; Young Hye Kang
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.